Human RETN/ADSF/FIZZ3 ORF/cDNA clone-Adenovirus particle (BC069302)
Cat. No.: vGMAP000284
Pre-made Human RETN/ADSF/FIZZ3 Adenovirus for RETN overexpression in-vitro and in-vivo. The RETN adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified RETN-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
RETN/ADSF products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP000284 | Human RETN Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP000284 |
| Gene Name | RETN |
| Accession Number | BC069302 |
| Gene ID | 56729 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 327 bp |
| Gene Alias | ADSF,FIZZ3,RETN1,RSTN,XCP1 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Kanamycin |
| ORF Nucleotide Sequence | ATGAAAGCTCTCTGTCTCCTCCTCCTCCCTGTCCTGGGGCTGTTGGTGTCTAGCAAGACCCTGTGCTCCATGGAAGAAGCCATCAATGAGAGGATCCAGGAGGTCGCCGGCTCCCTAATATTTAGGGCAATAAGCAGCATTGGCCTGGAGTGCCAGAGCGTCACCTCCAGGGGGGACCTGGCTACTTGCCCCCGAGGCTTCGCCGTCACCGGCTGCACTTGTGGCTCCGCCTGTGGCTCGTGGGATGTGCGCGCCGAGACCACATGTCACTGCCAGTGCGCGGGCATGGACTGGACCGGAGCGCGCTGCTGTCGTGTGCAGCCCTGA |
| ORF Protein Sequence | MKALCLLLLPVLGLLVSSKTLCSMEEAINERIQEVAGSLIFRAISSIGLECQSVTSRGDLATCPRGFAVTGCTCGSACGSWDVRAETTCHCQCAGMDWTGARCCRVQP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-SE1239-Ab | Anti-RETN/ ADSF/ FIZZ31 functional antibody |
| Target Antigen | GM-Tg-g-SE1239-Ag | RETN protein |
| Cytokine | cks-Tg-g-GM-SE1239 | resistin (RETN) protein & antibody |
| ORF Viral Vector | pGMLP001996 | Human RETN Lentivirus plasmid |
| ORF Viral Vector | pGMAP000284 | Human RETN Adenovirus plasmid |
| ORF Viral Vector | vGMLP001996 | Human RETN Lentivirus particle |
| ORF Viral Vector | vGMAP000284 | Human RETN Adenovirus particle |
Target information
| Target ID | GM-SE1239 |
| Target Name | RETN |
|
Gene Group Identifier (Target Gene ID in Homo species) |
56729 |
| Gene ID |
100060741 (Equus caballus), 100142685 (Felis catus), 246250 (Rattus norvegicus), 369020 (Bos taurus) 56729 (Homo sapiens), 57264 (Mus musculus), 611540 (Canis lupus familiaris), 708781 (Macaca mulatta) |
| Gene Symbols & Synonyms | RETN,Retn,RSTN,ADSF,RENT,XCP1,FIZZ3,RETN1,Rstn,Xcp4,Fizz3 |
| Target Alternative Names | ADSF,Adipose tissue-specific secretory factor (ADSF),C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein,Cysteine-rich secreted protein A12-alpha-like 2,Cysteine-rich secreted protein FIZZ3,FIZZ3,Fizz3,RENT,RETN,RETN1,RSTN,Resistin,Retn,Rstn,XCP1,Xcp4 |
| Uniprot Accession |
Q762I5,Q99P87,Q9HD89
Additional SwissProt Accessions: Q762I5,Q9HD89,Q99P87 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Cytokine Target |
| Disease | Sepsis, Malignant neoplasm of bladder |
| Disease from KEGG | |
| Gene Ensembl | ENSBTAG00000004716, ENSG00000104918, ENSMUSG00000012705, ENSCAFG00845027860, ENSMMUG00000050184 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


